{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:50Z","timestamp":1740144230297,"version":"3.37.3"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"crossref","award":["815590951"],"award-info":[{"award-number":["815590951"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"crossref","award":["81774400"],"award-info":[{"award-number":["81774400"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"crossref","award":["81973958"],"award-info":[{"award-number":["81973958"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"crossref","award":["81603708"],"award-info":[{"award-number":["81603708"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The aim of this systematic review and meta-analysis is to assess the cardiovascular (CV) risk of celecoxib on knee osteoarthritis (KOA) patients compared with the risk in those prescribed other non-selective non-steroidal anti-inflammatory drugs (NSAIDs), no intervention or placebo-controlled patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The following databases will be searched: MEDLINE, EMBASE, the Cochrane Library, Web of Science, Chinese Biomedical Literature Database, Chinese Nation Knowledge Infrastructure, Wanfang Database, and the Chongqing VIP from inception to April 1, 2020. All randomized controlled trials (RCTs) of celecoxib that presented data on serious cardiovascular events among KOA patients will be included. Study selection, data extraction, quality assessment, and assessment of risk bias will be performed by 2 reviewers independently. Odds ratios and correlative 95% confidence intervals will be calculated to present the association between the celecoxib and CV risk using Review Manager version 5.3 when there is sufficient available data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>This review does not require ethical approval. The results of this review may be published in a peer-reviewed journal or disseminated at relevant conferences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>CRD42020166721.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019976","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T03:35:02Z","timestamp":1588390502000},"page":"e19976","source":"Crossref","is-referenced-by-count":0,"title":["The cardiovascular risk of celecoxib for knee osteoarthritis"],"prefix":"10.1097","volume":"99","author":[{"given":"Shirui","family":"Cheng","sequence":"first","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xin","sequence":"additional","affiliation":[{"name":"The Rehabilitation Department, Chengdu Fifth People's Hospital, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"},{"name":"The Cheng Clinic Limited, London, England."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixing","family":"Xu","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanfang","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjie","family":"Li","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanrong","family":"Liang","sequence":"additional","affiliation":[{"name":"The Acupuncture and Tuina School\/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/ard.2009.113100","article-title":"EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis","volume":"69","author":"Zhang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-155-11-201112060-00004","article-title":"Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data","volume":"155","author":"Nguyen","year":"2011","journal-title":"Ann Intern Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/bmj.322.7294.1079","article-title":"Understanding the burden of musculoskeletal conditions. The burden is huge and not reflected in national health priorities","volume":"322","author":"Woolf","year":"2001","journal-title":"BMJ"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R9-20230915","first-page":"133","article-title":"TENS, electroacupuncture and ice massage: comparison of treatment for osteoarthritis of the knee","volume":"27","author":"Yurtkuran","year":"1999","journal-title":"Am J Acupunct"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/38.1.73","article-title":"Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization","volume":"38","author":"Dieppe","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1080\/14656566.2019.1645123","article-title":"Celecoxib for the treatment of musculoskeletal arthritis","volume":"20","author":"Krasselt","year":"2019","journal-title":"Expert opin pharmacother"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/jm0402059","article-title":"Adverse cardiovascular effects of the coxibs","volume":"48","author":"Dogn\u00e9","year":"2005","journal-title":"J Med Chem"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib","volume":"38","author":"Davies","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","article-title":"Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo","volume":"3","author":"Goldstein","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.117.027288","article-title":"Evaluating the cardiovascular safety of nonsteroidal anti-inflammatory drugs","volume":"135","author":"Antman","year":"2017","journal-title":"Circulation"},{"key":"R21-20230915","first-page":"1843","article-title":"Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)","volume":"38","author":"MacDonald","year":"2017","journal-title":"Eur Heart J"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/014107680609900315","article-title":"Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis","volume":"99","author":"Caldwell","year":"2006","journal-title":"J R Soc Med"},{"key":"R23-20230915","first-page":"5","article-title":"Celecoxib for osteoarthritis","author":"Puljak","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.296.13.jed60058","article-title":"COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense","volume":"296","author":"Graham","year":"2006","journal-title":"JAMA"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7326\/0003-4819-154-4-201102150-00016","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"154","author":"Bian","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:51:00Z","timestamp":1694818260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019976"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":26,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019976","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}